Currently, Precision is advancing its clinical trials with NEO-102, which is being developed as a therapeutic drug candidate for pancreatic and colorectal cancers. As part of the deal,
The drug is indicated for the treatment of type 2 diabetes mellitus in adults, to improve glucose control as monotherapy, when diet and exercise alone do not provide
By using Oracle Health Sciences Network, Joslin joins a growing list of healthcare provider participants which will expand clinical trial research for its patients through real-time collaboration with
The deal is initially aimed at using the companies’ complementary scientific platforms within the framework of ongoing research projects. Both the firms will assess results achieved to date,
The deal will combine integrated components to allow clinicians to use genomic data generated by laboratories more easily and efficiently to discover targeted therapeutic options suitable for each
The company will use the funding to advance its second clinical program with a new TCR to enter the clinic in the UK. Biomedical Catalyst Fund’s £2.1m grant
Launched in January 2008 for secondary hyperparathyroidism (HPT) in patients who are undergoing regular dialysis, Regpara tablets 25mg and 75mg acts on calcium receptors on the parathyroid gland
In April 2013, Valeant offered Actavis the rights to Metronidazole 1.3%, which provides a convenient, single-dose treatment for BV. BV is an infection caused by an imbalance in
Earlier in March 2013, the company had submitted the marketing authorization application (MAA) to the TGA for review of Latuda. Lurasidone is an atypical antipsychotic agent, developed by
Around 16 chronic HBV patients will be enrolled in multi-center, randomized, double-blind, placebo-controlled, dose-escalation Phase IIa trial, which is being conducted at Queen Mary Hospital and Prince of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.